A phase II prospective non-comparative multicenter clinical trial to determine the efficacy and safety of intrathecal liposomal cytarabine (DepoCyte) in preventing CNS-relapse in patients with aggressive Non-Hodgkin-Lymphomas treated with either R-CHOP 14 or R-CHOP 21 at risk for CNS metastasis.

Trial Profile

A phase II prospective non-comparative multicenter clinical trial to determine the efficacy and safety of intrathecal liposomal cytarabine (DepoCyte) in preventing CNS-relapse in patients with aggressive Non-Hodgkin-Lymphomas treated with either R-CHOP 14 or R-CHOP 21 at risk for CNS metastasis.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 05 Jul 2011

At a glance

  • Drugs Cytarabine (Primary)
  • Indications Carcinomatous meningitis; Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Sponsors Mundipharma International
  • Most Recent Events

    • 05 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top